Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains.
La Sala, G., Michiels, C., Kukenshoner, T., Brandstoetter, T., Maurer, B., Koide, A., Lau, K., Pojer, F., Koide, S., Sexl, V., Dumoutier, L., Hantschel, O.(2020) Nat Commun 11: 4115-4115
- PubMed: 32807795 
- DOI: 10.1038/s41467-020-17920-z
- Primary Citation of Related Structures:  
6TLC - PubMed Abstract: 
The transcription factor STAT3 is frequently activated in human solid and hematological malignancies and remains a challenging therapeutic target with no approved drugs to date. Here, we develop synthetic antibody mimetics, termed monobodies, to interfere with STAT3 signaling ...